Performant/$PHLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Performant
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
Ticker
$PHLT
Sector
Primary listing
Employees
964
Headquarters
Website
Performant Metrics
BasicAdvanced
$607M
-
-$0.01
0.41
-
Price and volume
Market cap
$607M
Beta
0.41
52-week high
$7.74
52-week low
$2.17
Average daily volume
2.2M
Financial strength
Current ratio
2.641
Quick ratio
2.443
Long term debt to equity
10.392
Total debt to equity
11.044
Interest coverage (TTM)
-0.04%
Profitability
EBITDA (TTM)
1.852
Gross margin (TTM)
23.66%
Net profit margin (TTM)
-0.64%
Operating margin (TTM)
-0.03%
Effective tax rate (TTM)
-1.96%
Revenue per employee (TTM)
$140,000
Management effectiveness
Return on assets (TTM)
-0.03%
Return on equity (TTM)
-1.12%
Valuation
Price to revenue (TTM)
4.376
Price to book
7.38
Price to tangible book (TTM)
17.4
Price to free cash flow (TTM)
-1,363.152
Free cash flow yield (TTM)
-0.07%
Free cash flow per share (TTM)
-0.006
Growth
Revenue change (TTM)
15.21%
Earnings per share change (TTM)
-86.30%
3-year revenue growth (CAGR)
6.75%
10-year revenue growth (CAGR)
-1.46%
3-year earnings per share growth (CAGR)
-56.17%
10-year earnings per share growth (CAGR)
-21.82%
What the Analysts think about Performant
Analyst ratings (Buy, Hold, Sell) for Performant stock.
Bulls say / Bears say
Total revenue jumped 22% year-over-year to $33.3 million in Q1 2025, with healthcare revenue rising 29% to $33.2 million, fueled by strong demand for payment integrity services (Nasdaq)
Adjusted EBITDA turned positive at $3.3 million in Q1 2025—versus a −$1.2 million loss a year ago—and adjusted net income was $1.2 million, marking the first profitable quarter under the new pure-play strategy (Nasdaq)
On August 1, 2025, Performant agreed to be bought by Machinify for $7.75 per share—a 139% premium to the 90-day VWAP—offering significant immediate gains for shareholders (Nasdaq)
Performed a net loss of $9.9 million for the full year 2024 and remains unprofitable over the trailing twelve months, with a −$5.96 million net loss, highlighting ongoing bottom-line challenges (Nasdaq)
Analyst sentiment is cautious: Performant was downgraded from “strong-buy” to “hold” by B. Riley on August 5, 2025, and five brokers have a consensus “Hold” rating, pointing to limited short-term upside (MarketBeat)
Cash and cash equivalents were about $9.98 million as of Q1 2025, well below the ~$33.1 million in operating expenses that quarter—raising liquidity concerns if additional financing is not secured (GuruFocus)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
Performant Financial Performance
Revenues and expenses
Performant Earnings Performance
Company profitability
Performant News
AllArticlesVideos
Shareholder Alert: The Ademi Firm Continues to Investigate Whether Performant Healthcare Inc. is Obtaining a Fair Price for its Public Shareholders
Business Wire4 hours ago
Shareholder Alert: The Ademi Firm Investigates Whether Performant Healthcare Inc. Is Obtaining a Fair Price for Its Public Shareholders
Business Wire1 month ago
PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc. - PHLT
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Performant stock?
Performant (PHLT) has a market cap of $607M as of September 15, 2025.
What is the P/E ratio for Performant stock?
The price to earnings (P/E) ratio for Performant (PHLT) stock is 0 as of September 15, 2025.
Does Performant stock pay dividends?
No, Performant (PHLT) stock does not pay dividends to its shareholders as of September 15, 2025.
When is the next Performant dividend payment date?
Performant (PHLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Performant?
Performant (PHLT) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.